TrialBMC gastroenterology2014

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).

Renate Schmelz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.